Skip to main content

Table 2 Baseline characteristics stratified by PCT-group

From: Procalcitonin-guided antibiotic treatment in patients with cancer: a patient-level meta-analysis from randomized controlled trials

Parameter

Control group (n = 398)

PCT group (n = 379)

p-value

Demographics

   

 Age [years] mean (SD)

69.8 (11.6)

69.1 (11.3)

0.38

 Male gender, n (%)

257 (64.6)

253 (66.8)

0.52

Diagnosis, n (%)

   

 Pneumonia (CAP, VAP)

39 (9.8)

38 (10.0)

0.42

 Lower and upper ARI

118 (29.6)

94 (24.8)

 

 AECOPD

26 (6.5)

22 (5.8)

 

 Sepsis/septic shock

215 (54.0)

225 (59.4)

 

Laboratory assessment

   

 PCT day 0 [µg/L], mean (SD)

10.7 (29.9)

11.6 (49.4)

0.78

 PCT cut-offs, n (%)

   

 PCT < 0.1 [µg/L]

37 (10.4)

46 (13.6)

0.14

 PCT 0.1–0.25 [µg/L]

72 (20.3)

45 (13.3)

 

 PCT > 0.25–0.5 [µg/L]

35 (9.9)

38 (11.2)

 

 PCT > 0.5 -2.0 [µg/L]

57 (16.1)

56 (16.5)

 

 PCT > 2.0–10’000 [µg/L]

154 (43.4)

154 (45.4)

 

 CRP day 0 [µg/L], mean (SD)

157.5 (114.2)

187.4 (274.2)

0.06

 Creatinine day 0 [µg/L], mean (SD)

127.7 (110.9)

142.3 (124.0)

0.12

Vital signs

   

Temperature [°C], mean (SD)

37.8 (1.1)

37.8 (1.0)

0.28

Setting, n (%)

   

 Emergency Department

178 (44.7)

151 (39.8)

0.17

 ICU

220 (55.3)

228 (60.2)

 

Sepsis score

   

 SOFA score [points], mean (SD)

9.1 (3.8)

8.5 (3.9)

0.22

Additional support

   

 Vassopressor use, n (%)

173 (80.5)

191 (84.5)

0.26

 Ventilation support, n (%)

157 (73.4)

167 (73.6)

0.96

 Renal replacement, n (%)

52 (13.1)

52 (13.7)

0.79

Comorbidities, n (%)

   

 Liver failure

47 (12.5)

40 (11.2)

0.57

 Congestive heart failure

90 (24.5)

88 (25.1)

0.85

 Central nervous system

34 (9.6)

29 (8.5)

0.62

 End-stage renal disease

96 (26.2)

77 (21.9)

0.18

 Peripheral artery disease

27 (8.2)

31 (10.0)

0.42

 Hypertension

55 (70)

46 (62)

0.33

 Diabetes mellitus

76 (20.8)

74 (21.1)

0.9

 Immunosupression

8 (4.6)

8 (4.3)

0.86

  1. Abbreviations: CAP, community acquired pneumonia; VAP, ventilator associated pneumonia; ARI, acute respiratory infection; AECOPD, acute exacerbation of chronic obstructive pulmonary disease; CRP, c-reactive protein; PCT, procalcitonin; SD, standard deviation; SOFA, sepsis-related Organ Failure Assessment; ICU, intensive care unit